Overview

Analysis of Changes in Adipose Tissue of Patients With Lipoatrophy HIV Infection Treated With Nucleoside Thymidine, After Switching to Monotherapy With Lopinavir / Ritonavir

Status:
Terminated

Trial end date:
2012-11-01

Target enrollment:

Participant gender:

Summary

The objective is to analyse the changes in the adipose tissue hystological features and the adipogenesis gene expression and related to inflammation after 48 and 96 weeks after the change from AZT+3TC+ABC (Trizivir®) to a monotherapy treatment with LPV/r (Kaletra®)

Phase:

Phase 4

Details

Lead Sponsor:

Ines Perez

Treatments:

Lopinavir
Ritonavir